We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$149M
AUM Growth
-$24.7M
Cap. Flow
-$23.3M
Cap. Flow %
-15.6%
Top 10 Hldgs %
62%
Holding
223
New
7
Increased
83
Reduced
107
Closed
23

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$459K
2
SNA icon
Snap-on
SNA
+$255K
3
WBA
Walgreens Boots Alliance
WBA
+$242K
4
HAS icon
Hasbro
HAS
+$233K
5
GIS icon
General Mills
GIS
+$226K

Sector Composition

Rank Sector Weight
1 Healthcare 22.01%
2 Industrials 8%
3 Technology 6.97%
4 Consumer Staples 6.72%
5 Consumer Discretionary 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
151
D.R. Horton
DHI
$40B
$225K 0.15%
2,098
-48
-2% -$5.75K
JNJ icon
152
Johnson & Johnson
JNJ
$618B
$225K 0.15%
1,446
+5
+0.3% +$825
PFE icon
153
Pfizer
PFE
$143B
$224K 0.15%
6,764
+858
+15% +$30.3K
EIX icon
154
Edison International
EIX
$28.2B
$223K 0.15%
3,529
-84
-2% -$5.85K
MRNA icon
155
Moderna
MRNA
$21.8B
$223K 0.15%
2,155
+287
+15% +$32K
LOW icon
156
Lowe's Companies
LOW
$117B
$222K 0.15%
1,069
-101
-9% -$22.7K
ETN icon
157
Eaton
ETN
$161B
$222K 0.15%
1,040
-263
-20% -$56.7K
BMY icon
158
Bristol-Myers Squibb
BMY
$133B
$221K 0.15%
3,808
+258
+7% +$15.8K
BF.B icon
159
Brown-Forman Class B
BF.B
$13.2B
$221K 0.15%
3,827
+33
+0.9% +$2.19K
MRK icon
160
Merck
MRK
$322B
$219K 0.15%
2,128
+53
+3% +$5.71K
CTLT
161
DELISTED
CATALENT, INC.
CTLT
$218K 0.15%
4,785
-1,149
-19% -$53.7K
ZTS icon
162
Zoetis
ZTS
$32.4B
$217K 0.15%
1,250
-165
-12% -$30K
SWKS icon
163
Skyworks Solutions
SWKS
$9.37B
$217K 0.15%
2,201
+113
+5% +$12K
NXPI icon
164
NXP Semiconductors
NXPI
$57.8B
$216K 0.14%
1,080
-91
-8% -$18.8K
KHC icon
165
Kraft Heinz
KHC
$30.7B
$215K 0.14%
6,406
+722
+13% +$24.9K
ADI icon
166
Analog Devices
ADI
$179B
$215K 0.14%
1,229
+39
+3% +$7.19K
SEDG icon
167
SolarEdge
SEDG
$2.51B
$214K 0.14%
1,655
+785
+90% +$151K
LLY icon
168
Eli Lilly
LLY
$1.02T
$213K 0.14%
396
-119
-23% -$61.3K
AVGO icon
169
Broadcom
AVGO
$1.85T
$213K 0.14%
2,560
-150
-6% -$13K
TXN icon
170
Texas Instruments
TXN
$252B
$211K 0.14%
1,329
+58
+5% +$9.9K
NEE icon
171
NextEra Energy
NEE
$181B
$211K 0.14%
3,687
+382
+12% +$26.4K
ADP icon
172
Automatic Data Processing
ADP
$106B
$211K 0.14%
877
-128
-13% -$31.2K
CPRT icon
173
Copart
CPRT
$27B
$211K 0.14%
4,890
-182
-4% -$8.09K
QRVO icon
174
Qorvo
QRVO
$7.99B
$211K 0.14%
2,206
-9
-0.4% -$919
GOOG icon
175
Alphabet (Google) Class C
GOOG
$4.36T
$210K 0.14%
1,596
-171
-10% -$22.2K

Similar funds

Vantage Consulting Group's Q3 2023 Portfolio in Review

As of Q3 2023, Vantage Consulting Group held 223 positions worth $149M, down 14% from $174M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Vantage Consulting Group withdrew a net $23.3M in Q3 2023, closing 23 positions and reducing 107 holdings. Its most notable exit was Booking.com, an estimated $230K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

Against the trend, Vantage Consulting Group opened a new position in Kenvue worth $398K.

  • Vantage Consulting Group's largest Q3 2023 buy was Kenvue: 19,827 shares worth $398K.
  • Vantage Consulting Group added most to Walgreens Boots Alliance in Q3 2023, an estimated $242K increase.
  • Vantage Consulting Group's biggest Q3 2023 reduction was Royalty Pharma, cutting an estimated $17.6M.
  • Vantage Consulting Group fully exited Booking.com in Q3 2023, selling an estimated $230K.
  • Vantage Consulting Group's ten largest holdings make up 62% of its $149M portfolio in Q3 2023.
  • Vantage Consulting Group opened 7 new positions and closed 23 in Q3 2023.
  • Vantage Consulting Group's portfolio value fell 14% quarter-over-quarter to $149M.

Based on Vantage Consulting Group's 13F filing for Q3 2023, filed 14 Nov 2023.